<DOC>
	<DOC>NCT02607670</DOC>
	<brief_summary>This is a Phase 2, randomized, double-blind, placebo-controlled study of TAT4 Gel for the reduction of moderate to severe nasolabial folds.</brief_summary>
	<brief_title>Phase 2 Study of TAT4 Gel for Reduction of Nasolabial Folds</brief_title>
	<detailed_description />
	<criteria>Moderate to severe, bilateral nasolabial folds Must understand and provide informed consent Pregnant or lactating women History of skin hypersensitivity of atopic dermatitis Any illness of disease that, in the investigator's opinion, would make trial participation inadvisable</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>January 2016</verification_date>
</DOC>